Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Single and Multiple Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 Injection in Healthy Subjects

NCT05308940 is registered in ClinicalTrials.gov with Shenzhen Turier Biotech Co., Ltd as lead sponsor.

NCT NCT05308940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05308940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Single and Multiple Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 Injection in Healthy Subjects
Lead sponsor
Shenzhen Turier Biotech Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
January 10, 2022
Completion date
August 23, 2022
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy